
Exagen XGN
$ 2.76
1.1%
Annual report 2025
added 03-10-2026
Exagen Long Term Debt Current 2011-2026 | XGN
Annual Long Term Debt Current Exagen
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.23 M | 1.1 M | 976 K | 1.04 M | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.23 M | 976 K | 1.08 M |
Long Term Debt Current of other stocks in the Diagnostics research industry
| Issuer | Long Term Debt Current | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Akumin
AKU
|
17.2 M | - | -17.87 % | $ 25.9 M | ||
|
Centogene N.V.
CNTG
|
2.18 M | - | -6.23 % | $ 30.6 M | ||
|
Castle Biosciences
CSTL
|
1.66 M | $ 24.24 | -1.86 % | $ 673 M | ||
|
Accelerate Diagnostics
AXDX
|
829 K | - | -61.36 % | $ 2.46 M | ||
|
Aspira Women's Health
AWH
|
202 K | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
518 K | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
915 K | - | 0.22 % | $ 16.8 M | ||
|
Neogen Corporation
NEOG
|
5.64 M | $ 9.01 | -3.53 % | $ 1.95 B | ||
|
Check-Cap Ltd.
CHEK
|
264 K | - | - | $ 9.42 M | ||
|
Koninklijke Philips N.V.
PHG
|
241 M | $ 25.58 | -5.68 % | $ 20 B | ||
|
Co-Diagnostics
CODX
|
662 K | $ 1.53 | -6.13 % | $ 2.04 M | ||
|
Personalis
PSNL
|
7.7 M | $ 5.04 | -8.36 % | $ 299 M | ||
|
CareDx, Inc
CDNA
|
6.52 M | $ 20.8 | -5.07 % | $ 1.11 B | ||
|
DermTech
DMTK
|
3.07 M | - | -11.32 % | $ 2.94 M | ||
|
Enzo Biochem
ENZ
|
841 K | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
33.6 M | - | - | $ 19.8 B | ||
|
Fulgent Genetics
FLGT
|
1.44 M | $ 14.8 | -3.27 % | $ 447 M | ||
|
Illumina
ILMN
|
79 M | $ 120.37 | -5.16 % | $ 19.1 B | ||
|
Global Cord Blood Corporation
CO
|
147 K | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
264 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
21.5 M | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
57.7 M | $ 163.84 | -1.77 % | $ 8.12 B | ||
|
HTG Molecular Diagnostics
HTGM
|
475 K | - | -20.0 % | $ 1.06 M | ||
|
Guardant Health
GH
|
27.7 M | $ 83.41 | 0.35 % | $ 10.5 B | ||
|
Twist Bioscience Corporation
TWST
|
13.8 M | $ 56.7 | -4.14 % | $ 3.39 B | ||
|
Lantheus Holdings
LNTH
|
3.8 M | $ 81.17 | -2.85 % | $ 5.48 B | ||
|
Heska Corporation
HSKA
|
2.94 M | - | - | $ 1.31 B | ||
|
Interpace Biosciences
IDXG
|
431 K | $ 1.99 | 2.9 % | $ 8.8 M | ||
|
Senseonics Holdings
SENS
|
496 K | $ 6.43 | -10.52 % | $ 268 M | ||
|
QIAGEN N.V.
QGEN
|
23.4 M | - | - | $ 10.6 B | ||
|
Medpace Holdings
MEDP
|
23.2 M | $ 413.59 | 0.93 % | $ 11.9 B | ||
|
Biomerica
BMRA
|
358 K | $ 2.16 | -1.22 % | $ 4.96 M | ||
|
Motus GI Holdings
MOTS
|
169 K | - | -34.28 % | $ 263 K | ||
|
ICON Public Limited Company
ICLR
|
24.3 M | $ 116.17 | 13.35 % | $ 9.58 B | ||
|
Laboratory Corporation of America Holdings
LH
|
191 M | $ 257.14 | -0.94 % | $ 21.4 B | ||
|
NeoGenomics
NEO
|
4.78 M | $ 8.96 | -0.67 % | $ 1.15 B | ||
|
Celcuity
CELC
|
54 K | $ 119.0 | -0.89 % | $ 5.56 B | ||
|
National Research Corporation
NRC
|
451 K | $ 16.54 | -1.78 % | $ 370 M | ||
|
Myriad Genetics
MYGN
|
6.9 M | $ 4.68 | -3.31 % | $ 433 M | ||
|
Natera
NTRA
|
7.64 M | $ 194.75 | -2.71 % | $ 19.2 B | ||
|
Quest Diagnostics Incorporated
DGX
|
174 M | $ 189.32 | -2.94 % | $ 21 B | ||
|
Invitae Corporation
NVTA
|
14.6 M | - | - | $ 21.2 M | ||
|
OpGen
OPGN
|
174 K | - | -16.95 % | $ 1.54 M | ||
|
Organovo Holdings
ONVO
|
521 K | - | -2.3 % | $ 19.4 M |